Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
VTYX
11051
PUT
DELISTED
Ventyx Biosciences
VTYX
| $130K | ﹤0.01% |
59,300
+21,400
| +56% | +$48.5K |
2022 Q3
9 quarters
|
|
|
OKLO
11052
Oklo
OKLO
$6.57B
| $130K | ﹤0.01% |
6,111
-25,569
| -81% | -$496K |
2024 Q2
2 quarters
|
|
|
GDEN
11053
PUT
DELISTED
Golden Entertainment
GDEN
| $130K | ﹤0.01% |
4,100
-20,100
| -83% | -$638K |
2022 Q4
8 quarters
|
|
11054
PUT
iShares MSCI Italy ETF
EWI
$1.13B
| $129K | ﹤0.01% |
3,600
+200
| +6% | +$7.45K |
2022 Q3
9 quarters
|
|
11055
CALL
VanEck ChiNext Innovators ETF
CNXT
$91.2M
| $129K | ﹤0.01% |
4,700
-7,800
| -62% | -$233K |
2024 Q3
1 quarter
|
|
11056
PUT
SouthState Bank Corp
SSB
$9.55B
| $129K | ﹤0.01% |
1,300
-2,300
| -64% | -$237K |
2020 Q4
16 quarters
|
|
11057
CALL
Banco Bilbao Vizcaya Argentaria
BBVA
$143B
| $129K | ﹤0.01% |
13,300
+11,500
| +639% | +$114K |
2022 Q1
11 quarters
|
|
|
LICY
11058
PUT
DELISTED
Li-Cycle Holdings Corp.
LICY
| $129K | ﹤0.01% |
72,200
+38,500
| +114% | +$83.1K |
2021 Q3
13 quarters
|
|
11059
PUT
Veru
VERU
$41.6M
| $129K | ﹤0.01% |
19,800
-6,190
| -24% | -$45.9K |
2020 Q4
16 quarters
|
|
11060
CALL
Lands' End
LE
$309M
| $129K | ﹤0.01% |
9,800
+400
| +4% | +$6.27K |
2022 Q4
8 quarters
|
|
11061
Annexon
ANNX
$737M
| $129K | ﹤0.01% |
25,098
+19,460
| +345% | +$120K |
2024 Q3
1 quarter
|
|
11062
CALL
State Street SPDR ICE Preferred Securities ETF
PSK
$627M
| $129K | ﹤0.01% |
+3,900
| New | +$135K |
2024 Q4
0 quarters
|
|
|
AIFU
11063
AIFU Inc
AIFU
$73.8M
| $128K | ﹤0.01% |
292
+162
| +125% | +$86.5K |
2024 Q2
2 quarters
|
|
|
SNCY
11064
PUT
DELISTED
Sun Country Airlines
SNCY
| $128K | ﹤0.01% |
8,800
+400
| +5% | +$5.43K |
2022 Q4
8 quarters
|
|
11065
PUT
Korn Ferry
KFY
$3.97B
| $128K | ﹤0.01% |
1,900
+300
| +19% | +$21.8K |
2022 Q4
8 quarters
|
|
11066
CALL
Verra Mobility
VRRM
$444M
| $128K | ﹤0.01% |
5,300
-14,800
| -74% | -$367K |
2020 Q3
17 quarters
|
|
11067
CALL
Scholastic
SCHL
$693M
| $128K | ﹤0.01% |
6,000
-6,900
| -53% | -$175K |
2022 Q4
8 quarters
|
|
11068
BlackRock Core Bond Trust
BHK
$582M
| $128K | ﹤0.01% |
+12,220
| New | +$138K |
2024 Q4
0 quarters
|
|
11069
Nuveen Real Estate Income Fund
JRS
$207M
| $128K | ﹤0.01% |
+14,793
| New | +$134K |
2024 Q4
0 quarters
|
|
|
LAR
11070
Lithium Argentina AG
LAR
$868M
| $127K | ﹤0.01% |
48,450
+42,588
| +727% | +$139K |
2023 Q4
4 quarters
|
|
11071
CALL
Hain Celestial
HAIN
$49.8M
| $127K | ﹤0.01% |
20,600
-36,400
| -64% | -$291K |
2013 Q2
46 quarters
|
|
|
MODV
11072
PUT
DELISTED
ModivCare
MODV
| $127K | ﹤0.01% |
10,700
-7,200
| -40% | -$114K |
2022 Q3
9 quarters
|
|
11073
PUT
Coherus Oncology
CHRS
$152M
| $127K | ﹤0.01% |
91,800
+52,300
| +132% | +$58.7K |
2022 Q4
8 quarters
|
|
11074
CALL
Sight Sciences
SGHT
$434M
| $127K | ﹤0.01% |
34,800
+7,500
| +27% | +$34.2K |
2024 Q1
3 quarters
|
|
11075
Gossamer Bio
GOSS
$61.8M
| $127K | ﹤0.01% |
1,750
-11,251
| -87% | -$771K |
2023 Q1
7 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.